Displaying 121 - 132 of 160
Immune-Mediated and Cholestatic Diseases
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Unmet needs in PBC: the patient perspective

Unmet needs in PBC: the patient perspective

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Welcome & objectives

Welcome & objectives

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC

Key considerations in the management of cirrhosis in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?

Does our increasing knowledge of PBC pathogenesis affect early management?

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC

Enhancing clinical care strategies in PBC

Webcasts
View
Viral Hepatitis
Overview of HBV antigens and relevance to functional cure

Overview of HBV antigens and relevance to functional cure

Webcasts
View
Viral Hepatitis
Discussion / Q&A

Discussion / Q&A

Webcasts
View
Viral Hepatitis
Welcome and Introduction

Welcome and Introduction

Webcasts
View
Viral Hepatitis
Plenary – ‘Short Duration DAAs: Fuelling the Journey to HCV Elimination’

Plenary – ‘Short Duration DAAs: Fuelling the Journey to HCV Elimination’

Webcasts
View
Displaying 121 - 132 of 160